TRAVERE THERAPEUTICS INC

CUSIP: 89422GAA5 Class: Convertible Debt

Context Capital Management, LLC's Holding History (CIK: 0001301396)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 57,457,000 Value ($000) $81,991 Avg Close — Range —
Q3 2025
Shares 46,354 Value ($000) $52,492 Avg Close — Range —
Q2 2025
Shares 37,978 Value ($000) $36,270 Avg Close — Range —
Q1 2025
Shares 35,293 Value ($000) $35,258 Avg Close — Range —
Q4 2024
Shares 49,863 Value ($000) $47,736 Avg Close — Range —
Q3 2024
Shares 56,817 Value ($000) $49,090 Avg Close — Range —
Q2 2024
Shares 60,742 Value ($000) $39,558 Avg Close — Range —
Q1 2024
Shares 61,017 Value ($000) $39,030 Avg Close — Range —
Q4 2023
Shares 53,392,000 Value ($000) $35,239 Avg Close — Range —
Q3 2023
Shares 41,167 Value ($000) $27 Avg Close — Range —
Q2 2023
Shares 29,167 Value ($000) $23 Avg Close — Range —
Q1 2023
Shares 18,167 Value ($000) $18 Avg Close — Range —
Q4 2022
Shares 23,167 Value ($000) $21 Avg Close — Range —
Q3 2022
Shares 5,000 Value ($000) $5,088 Avg Close — Range —
Q2 2022
Shares 4,100 Value ($000) $4,092 Avg Close — Range —
Q1 2022
Shares 5,750 Value ($000) $6,138 Avg Close — Range —